Moreover, in breast cancer models, curcumin decreased the expression of PD-L1 in cancer cells leading to improvement of antitumor efficacy, and thus sensitizing cancer cells to anti-CTLA-4 therapy [151]. The gene discussed is CTLA4; the disease is breast carcinoma.